Get started
Overview
Financials
News Discussions Technicals Forecast Seasonals

2228 fundamentals

Key facts

Market capitalization‪27.33 B‬HKD
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)−2.25HKD
Founded2015
Employees (FY)783
CEOJian Ma
Websitextalpi.com
About

XtalPi Holdings Ltd. provides drug and material science R&D solutions and services to global conglomerates and companies in the pharmaceutical and material science industries. Its services include drug discovery solutions and intelligent automation solutions. The company was founded by Lai Li Ppeng, Ma Jian and Wen Shu Hao in 2015 and is headquartered in Shenzhen, China.

Ownership
‪‪4.02 B‬‬
Closely held shares
‪‪2.06 B‬‬ (51.16%)
Free Float shares
‪‪1.96 B‬‬ (48.84%)
Closely held shares
‪‪2.06 B‬‬ (51.16%)
Free Float shares
‪‪1.96 B‬‬ (48.84%)
Capital structure
Market cap
‪‪27.33 B‬‬
Debt
‪‪175.76 M‬‬
Minority interest
‪‪27.77 M‬‬
Cash & equivalents
‪‪3.63 B‬‬
Enterprise value
‪‪23.91 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪27.33 B‬‬
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
21.85x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
21.85x
Valuation ratios
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24

Growth and Profitability

Company’s recent performance and margins

Performance
‪−1,390.00%‬
‪−1,230.00%‬
‪−1,070.00%‬
‪−910.00%‬
‪−750.00%‬
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
‪‪−1.50 B‬‬
‪‪−1.00 B‬‬
‪‪−500.00 M‬‬
‪0.00‬
‪‪500.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−1.50 B‬‬
‪‪−1.00 B‬‬
‪‪−500.00 M‬‬
‪0.00‬
‪‪500.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−1.50 B‬‬
‪‪−1.00 B‬‬
‪‪−500.00 M‬‬
‪0.00‬
‪‪500.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Drug Discovery Solutions
Automated Chemical Synthesis Services
Solid State Research & Development Services
Other
By country
Period: 2023
China
United States
Other Areas

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
H2 '23
H1 '24
H2 '24
‪0.00‬
‪‪30.00 M‬‬
‪‪60.00 M‬‬
‪‪90.00 M‬‬
‪‪120.00 M‬‬
Actual
Earnings
Next:Mar 28, 2025
H2 '23
H1 '24
H2 '24
‪−2.00‬
‪−1.50‬
‪−1.00‬
‪−0.50‬
‪0.00‬
Actual

Dividends

Dividend yield, history and sustainability

2228 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
‪‪−4.50 B‬‬
‪0.00‬
‪‪4.50 B‬‬
‪‪9.00 B‬‬
‪‪13.50 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪1.00 B‬‬
‪‪2.00 B‬‬
‪‪3.00 B‬‬
‪‪4.00 B‬‬
Assets
Liabilities